Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness in Men and Women at Moderate Risk for Coronary Heart Disease

American Journal of Cardiology

Volumn 104, Issue 7, 2009, Pages 936-942

  Davidson, Michael H ^a   Maki, Kevin C ^c   Dicklin, Mary R ^c   Feinstein, Steven B ^b   Witchger, MarySue ^c   Bell, Marjorie ^c   McGuire, Darren K ^d   Provost, Jean Claude ^e   Liker, Harley ^f   Aviram, Michael ^g  

^a UNIVERSITY OF CHICAGO   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c Provident Clinical Research   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e Synarc   (France)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID PEROXIDE; TRIACYLGLYCEROL;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; OXIDATIVE STRESS; POMEGRANATE JUICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTIOXIDANTS; BEVERAGES; CAROTID ARTERIES; CAROTID STENOSIS; CORONARY DISEASE; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FLAVONOIDS; FOLLOW-UP STUDIES; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; PHENOLS; PHYTOTHERAPY; PUNICACEAE; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUNICA INTIMA; TUNICA MEDIA;

EID: 70249150742     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.05.037     Document Type: Article

References (30)

1. Gil M.I., Tomás-Barberán F.A., Hess-Pierce B., Holcroft D.M., and Kader A.A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48 (2000) 4581-4589
2. Aviram M., Dornfeld L., Rosenblat M., Volkova N., Kaplan M., Coleman R., Hayek T., Presser D., and Fuhrman B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71 (2000) 1062-1076
3. Aviram M., and Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158 (2001) 195-198
4. Kaplan M., Hayek T., Raz A., Coleman R., Dornfeld L., Vaya J., and Aviram M. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr 131 (2001) 2082-2089
5. Aviram M., Rosenblat M., Gaitini D., Nitecki S., Hoffman A., Dornfeld L., Volkova N., Presser D., Attias J., Liker H., and Hayek T. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23 (2004) 423-433
6. Sumner M.D., Elliott-Eller M., Weidner G., Daubenmier J.J., Chew M.H., Marlin R., Raisin C.J., and Ornish D. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am J Cardiol 96 (2005) 810-814
7. Ignarro L.J., Byrns R.E., Sumi D., de Nigris F., and Napoli C. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric Oxide 15 (2006) 93-102
8. Rosenblat M., Hayek T., and Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis 187 (2006) 363-371
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
10. Mazzone T., Meyer P.M., Feinstein S.B., Davidson M.H., Kondos G.T., D'Agostino Sr. R.B., Perez A., Provost J.C., and Haffner S.M. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA 296 (2006) 2572-2581
11. Gariepy J., Salomon J., Denarié N., Laskri F., Megnien J.L., Levenson J., and Simon A. Sex and topographic differences in associations between large-artery wall thickness and coronary risk profile in a French working cohort: the AXA study. Arterioscler Thromb Vasc Biol 18 (1998) 584-590
12. Simon A., Gariepy J., Moyse D., and Levenson J. Differential effects of nifedipine and co-amilozide on progression of early carotid wall changes. Circulation 103 (2001) 2949-2954
13. Macioch J.E., Katsamakis C.D., Robin J., Liebson P.R., Meyer P.M., Geohas C., Raichlen J.S., Davidson M.H., and Feinstein S.B. Effect of contrast enhancement on measurement of carotid artery intimal medial thickness. Vasc Med 9 (2004) 7-12
14. Ledue T.B., and Rifai N. High sensitivity immunoassays for C-reactive protein: promises and pitfalls. Clin Chem Lab Med 39 (2001) 1171-1176
15. Benzie I.F., and Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239 (1996) 70-76
16. Gan K., Smole A., Eckerson H.W., and La Du B.N. Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab Dispos 19 (1991) 100-106
17. Frei B., Stocker R., and Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A 85 (1988) 9748-9752
18. El-Saadani M., Esterbauer N., El-Sayed M., Goher M., Nassar A.Y., and Jurgens G. Spectrophotometric assay for lipid peroxides in serum lipoproteins using commercially available reagent. J Lipid Res 30 (1989) 627-630
19. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302-310
20. Bland J.M., and Altman D.G. Measuring agreement in method comparison studies. Stat Methods Med Res 8 (1999) 135-160
21. Liu M.L., Ylitalo K., Salonen R., Salonen J.T., and Taskinen M.R. Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 24 (2004) 1492-1497
22. Wallenfeldt K., Fagerberg B., Wikstrand J., and Hulthe J. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med 256 (2004) 413-420
23. Carotid atorvastatin study in hyperlipidemic post-menopausal women: a randomized evaluation of atorvastatin versus placebo (CASHMERE). http://www.clinicalstudyresults.org/drugdetails/?drug_name_id=156&sort=c.company_name&page=2&drug_id=2902 Accessed November 16, 2008
24. Brown B.G., and Taylor A.J. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe. N Engl J Med 358 (2008) 1504-1507
25. Drazen J.M., Jarcho J.A., Morrissey S., and Curfman G.D. Cholesterol lowering and ezetimibe. N Engl J Med 358 (2008) 1507-1508
26. Kastelein J.J.P., Akdim F., Stroes E.S., Zwinderman A.H., Bots M.L., Stalenhoef A.F., Visseren F.L., Sljbrands E.J., Trip M.D., Stein E.A., Gaudet D., Duivenvoorden R., Veltri E.P., Marais A.D., de Groot E., and ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 358 (2008) 1431-1443
27. Stein E.A. Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: More clarity or confusion?. J Am Coll Cardiol 52 (2008) 2206-2209
28. Poredos P. Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis. Vasc Med 9 (2004) 46-54
29. Aviram M. Dietary antioxidants stimulate the expression of paraoxonases which provides protection against atherosclerosis development. Curr Top Nutraceutical Res 3 (2003) 161-169
30. Polagruto J.A., Schramm D.D., Wang-Polagruto J.F., Lee L., and Keen C.L. Effects of flavonoids-rich beverages on prostacyclin synthesis in humans and human aortic endothelial cells: association with ex vivo platelet function. J Med Food 6 (2003) 301-308